Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clarity Pharmaceuticals Ltd. (AU:CU6)
ASX:CU6
RESEARCH TOOLSreports
Holding AU:CU6?
Track your performance easily
CU6 Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$1.07 - AU$8.98
Previous CloseAU$7.01
Volume104.10K
Average Volume (3M)1.97M
Market Cap
AU$2.24B
Enterprise ValueAU$2.15B
Total Cash (Recent Filing)AU$92.34M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Feb 26, 2025EPS Estimate
-AU$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares OutstandingN/A
10 Day Avg. Volume1,065,125
30 Day Avg. Volume1,974,551
Standard Deviation0.21
R-Squared0.09
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$8.34Price Target Upside14.72% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Clarity Pharmaceuticals Ltd. News
PremiumCompany Announcements
Clarity Pharmaceuticals Gains from New CMS Reimbursement Rule
PremiumCompany Announcements
Clarity Pharmaceuticals Issues New Employee Incentive Options
PremiumCompany Announcements
Clarity Pharmaceuticals: Strong Cash Position and Trial Progress
PremiumCompany Announcements
Clarity Pharmaceuticals Expands Market Presence with New Share Issue
PremiumCompany Announcements
Clarity Pharmaceuticals Sets Date for 2024 AGM
PremiumCompany Announcements
Clarity Pharmaceuticals Lists New Securities on ASXPremiumCompany Announcements
Clarity Pharmaceuticals Sees Positive Results in Cancer Trial
PremiumCompany Announcements
Clarity Pharmaceuticals Advances Prostate Cancer DiagnosticOptions Prices
Currently, No data available
---
Ownership Overview
13.06% Insiders
0.08% Mutual Funds
― Other Institutional Investors
84.67% Public Companies and
Individual Investors
CU6 FAQ
What was Clarity Pharmaceuticals Ltd.’s price range in the past 12 months?
Clarity Pharmaceuticals Ltd. lowest share price was AU$1.07 and its highest was AU$8.97 in the past 12 months.
What is Clarity Pharmaceuticals Ltd.’s market cap?
Currently, no data Available
When is Clarity Pharmaceuticals Ltd.’s upcoming earnings report date?
Clarity Pharmaceuticals Ltd.’s upcoming earnings report date is Feb 26, 2025 which is in 109 days.
How were Clarity Pharmaceuticals Ltd.’s earnings last quarter?
Clarity Pharmaceuticals Ltd. released its earnings results on Aug 23, 2024. The company reported -AU$0.059 earnings per share for the quarter, missing the consensus estimate of -AU$0.052 by -AU$0.007.
Is Clarity Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Clarity Pharmaceuticals Ltd.’s price is currently Undervalued.
Does Clarity Pharmaceuticals Ltd. pay dividends?
Clarity Pharmaceuticals Ltd. does not currently pay dividends.
What is Clarity Pharmaceuticals Ltd.’s EPS estimate?
Clarity Pharmaceuticals Ltd.’s EPS estimate is -AU$0.07.
How many shares outstanding does Clarity Pharmaceuticals Ltd. have?
Clarity Pharmaceuticals Ltd. has 320,211,460 shares outstanding.
What happened to Clarity Pharmaceuticals Ltd.’s price movement after its last earnings report?
Clarity Pharmaceuticals Ltd. reported an EPS of -AU$0.059 in its last earnings report, missing expectations of -AU$0.052. Following the earnings report the stock price went down -2.467%.
Which hedge fund is a major shareholder of Clarity Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:CU6
---
Clarity Pharmaceuticals Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$8.34 (14.72% Upside)
AU$8.34 (14.72% Upside)
Blogger Sentiment
Bullish
AU:CU6 Sentiment 95%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
528.13%
12-Months-Change
Fundamentals
Return on Equity
-39.29%
Trailing 12-Months
Asset Growth
101.09%
Trailing 12-Months
Company Description
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.
---
CU6 Stock 12 Month Forecast
Average Price Target
AU$8.34
▲(14.72% Upside)
Technical Analysis
Race Oncology Ltd.
―
Cyclopharm Limited
―
Alcidion Group Limited
―
Proteomics International Laboratories Ltd.
―
Best Analysts Covering CU6
1 Year
1 Year Success Rate
7/7 ratings generated profit
1 Year Average Return
+146.21%
reiterated a buy rating 3 months ago
Copying John Hester's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +146.21% per trade.
---